Design Therapeutics, Inc.
DSGN
$10.30
-$0.74-6.70%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 5.88% | 10.93% | -7.72% | -29.77% | -4.69% |
| Total Depreciation and Amortization | 0.65% | 1.97% | -4.40% | 6.71% | -2.61% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.52% | -19.45% | 41.25% | 21.92% | 22.07% |
| Change in Net Operating Assets | -66.48% | 188.13% | 158.20% | -205.96% | -3.88% |
| Cash from Operations | -7.20% | 22.71% | 13.99% | -70.27% | -3.29% |
| Capital Expenditure | -- | 100.00% | -20.83% | -- | -100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -277.40% | -67.78% | 154.38% | 333.52% | 131.36% |
| Cash from Investing | -277.93% | -67.64% | 155.60% | 329.59% | 131.45% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 68,324.32% | -89.75% | 1,469.57% | -91.25% | 26,200.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 68,324.32% | -89.75% | 1,469.57% | -91.25% | 26,200.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 138.31% | -176.46% | 167.85% | -14.57% | 49.48% |